- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01142544
Incidence of Acute Lung Injury in Children (PED-ALIEN)
Acute Lung Injury in Children: Epidemiology and Natural History: The Pediatric ALIEN Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We will evaluate oxygenation under standard ventilator settings (FiO2 0.5 and 1 on PEEP 5 or 10 cmH2O) in pediatric acute respiratory distress syndrome.
Outcome measures will include: overall ICU mortality, number of patients meeting ARDS criteria at 24 hours, and stratification of patients depending on PaO2/FiO2 ratio at 24 h of meeting acute respiratory distress syndrome criteria.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Las Palmas
-
Las Palmas de Gran Canaria, Las Palmas, Spain, 35010
- Jesús Villar
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Acute onset of respiratory failure
- Age 1 month to 18 years old
- Bilateral pulmonary infiltrates on Chest X-ray
- Absence of left ventricular failure, PaO2/FiO2>300 mmHg
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pediatric ALIEN
All children from 1 month to 18 years old meeting the American-European Consensus Conference definition of acute lung injury
|
Measure of PaO2 under standard FiO2-PEEP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of cases of acute lung injury per 100,000 population
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of degree of lung severity at onset and at 24 h of the onset of acute lung injury
Time Frame: 1-year
|
1-year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jesús Villar, MD, PhD, Hospital Dr. Negrin, Las Palmas de Gran Canaria, Spain
- Principal Investigator: Robert M Kacmarek, RRT, PhD, Massachusetts general Hospital, Boston USA
- Principal Investigator: Yolanda López, MD, PhD, Hospital de Cruces, Barakaldo, Vizcaya, Spain
- Principal Investigator: Amelia Martínez, MD, PhD, Hospital Infantil del Niño Jesús, Madrid, Spain
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-0915-PED-ALI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.